Barry J. Regan
CIK 1746313 · EVP Operations · last filed 2023-12-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DXCM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MEMPHIS, TN 38117
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DXCM | EVP Operations | 58,469 | $83.58 | $4.89M | -$2.94M | 16 | 2023-12-19 |
| Wright Medical Group N.V. (WMGI) Delisted | SVP, Operations | 42,511 | — | — | -$304.2K | 5 | 2020-08-19 |
| Wright Medical Group N.V. (WMGIZ) Delisted | Sr. Vice President, Operations | 21,947 | — | — | $0 | 1 | 2018-07-26 |
Recent Filings · Page 2 of 3
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-10 | DXCM | Grant (A) | +18,776 | $19 | EDGAR |
| 2023-01-31 | DXCM | Sell (S) | −2,213 | -$234.8K | EDGAR |
| 2022-11-22 | DXCM | Disp (D) | −3,781 | -$425.8K | EDGAR |
| 2022-03-30 | DXCM | Sell (S) | −1,106 | -$553.0K | EDGAR |
| 2022-03-10 | DXCM | Mixed | +4,323 | -$268.4K | EDGAR |
| 2021-12-17 | DXCM | Grant (A) | +1,671 | $2 | EDGAR |
| 2021-12-14 | DXCM | Sell (S) | −1,214 | -$684.6K | EDGAR |
| 2021-11-23 | DXCM | Sell (S) | −837 | -$534.6K | EDGAR |
| 2021-03-10 | DXCM | Grant (A) | +5,301 | $5 | EDGAR |
| 2020-11-20 | DXCM | Grant (A) | +8,207 | $8 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
2 sales · $542.2K| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2024-01-16 | DXCM | 2,735 | $338.1K | $123.63 | 2024-03-04 |
| 2023-12-18 | DXCM | 1,675 | $204.1K | $121.85 | 2024-03-04 |